Maximum: 1 CME cr.,
1 AutoAttendance cr.
Sign in to view your progression
Program Overview Progr...
Learning Objectives Learn...
Target Audience Targe...
References Refer...
Disclosure/Disclaimer Discl...

Activity Title: Infection Prevention & Control in the Wake of COVID-19

Release Date: March 16, 2021

Estimated Time to Complete Activity: 70 minutes

Statement of Need:

The ongoing COVID-19 pandemic has highlighted  challenges and opportunities for infection control practices at healthcare facilities around the globe. In this moderated discussion, infection prevention and control experts  describe how they responded to the pandemic and what they did to quickly adapt existing healthcare protocols. Speakers will describe how these approaches and the lessons learned from the COVID-19 pandemic can help us better prepare for future outbreaks

Faculty:

Professor Gonzalo Martin Llorens Bearman
MD, MPH, FACP, FSHEA, FIDSA
Gonzalo Bearman is Chair of the Division of Infectious Diseases. He is a graduate of Colgate University (BA), SUNY at Buffalo School of Medicine and Biomedical Sciences (MD) and Columbia University (MPH). Dr. Bearman is Board Certified in Internal Medicine, Infectious Diseases, and General Preventive Medicine and Public Health.

Professor Ziad A. Memish
MD, FRCPC, FRCPE, FRCPL, FACP, FFPH
Ziad Memish is currently senior consultant in infectious diseases and Director of research & Innovation Center at King Saud Medical City, Ministry of Health. Professor at the College of Medicine in Alfaisal University, Riyadh, Saudi Arabia; and Adjunct Professor in the Hubert Department of Global Health, Rollins School of Public Health, Emory University, Georgia, USA. Professor Memish is Board certified by the American Board of Internal Medicine, the American Board of Infectious Diseases as well as a Fellow of the Royal College of Physicians (Canada, Edinburgh and London) and the American College of Physicians. 

Professor Michael Stevens
MD, MPH
Mike Stevens, MD, MPH, is a Professor of Internal Medicine in the Division of Infectious Diseases at Virginia Commonwealth University (VCU) in Richmond, VA. He is Director of the Antimicrobial Stewardship Program, an Associate Hospital Epidemiologist, Director of the health system's Travel & Tropical Medicine clinic and the Associate Chair for the Division of Infectious Diseases.  He has been an editor on ISID’s Guide to Infection Control in the Healthcare Setting since 2013.

Professor Victor Rosenthal
Dr. Rosenthal is specialist in Internal Medicine and in ID. He is certified on Infection Control and Hospital Epidemiology. He was a fellow of ID at University of Wisconsin. He finished post graduate course of the Program of Clinical Effectiveness of Harvard University.

Dr. Michelle Doll
MD, MPH
Michelle Doll, MD, MPH is an Assistant Professor of Internal Medicine at Virginia Commonwealth University (VCU) where she is also an Associate Hospital Epidemiologist for the Hospital Infection Prevention Program. She is board certified in Internal Medicine and Infectious Disease. 

Professor Shaheen Mehtar
MBBS, FRCPath (Eng), FCPath (SAfrica), MD (Lon)
Shaheen Mehtar is Professor(retired) at the Unit for Infection Prevention and Control (UIPC), Division of Global Health, Faculty of Health Sciences, Stellenbosch University, South Africa. She trained in the United Kingdom in Medical Microbiology, Infectious Disease and Community Health. Following a post as Deputy Director of Public Health in the South Cape Karoo region, she moved to Tygerberg Hospital and Stellenbosch University where she established the Unit of Infection Prevention and Control in 2004. 

Professor Folasade Tolulope Ogunsola
MBChB, PhD, FMCPath, FWACP, FNAMed. FAS
Folasade Ogunsola is a Professor of Clinical Microbiology at the College of Medicine University of Lagos, Nigeria. She was a founding member of the Nigerian Society for Infection Control in 1998 and has assisted in setting up infection control programs in institutions in the country. She was the Chair of the Infection Control Committee and of the Antibiotic policy committee of the Lagos University Teaching Hospital. 

Technical Requirements

This site and its activities are best viewed using the latest versions of the Chrome, Edge, Firefox and Safari browsers. For interactive content a broadband connection is required. For CME/CE activities featuring audio you need a sound card and speakers.

Our activities may require JavaScript to be enabled on your computer. If you are having difficulty viewing pop-up windows, click here for instructions on enabling JavaScript.

Contact Information

If you have questions about this CME activity, please contact The International Society for Infectious Diseases at info@isid.org.

For technical support issues, please contact Multilearning at support@multilearning.com

Upon completion of this module, participants should be able to::

  • Discuss how the ongoing COVID-19 pandemic has highlighted both challenges and opportunities for infection control practices at healthcare facilities around the globe
  • Discuss how infection prevention and control experts responded to the pandemic and what they did to quickly adapt existing healthcare protocols 
  • Describe how these approaches and the lessons learned from the COVID-19 pandemic can help us better prepare for future outbreaks.

The target audience for this module is physicians, nurses, public health officials, researchers, immunization officers, and other health professionals.

ISID Guide to Infection Control in the Healthcare Setting (open access): https://isid.org/guide/
 

Infection Control Africa Network (ICAN): http://www.icanetwork.co.za

International Nosocomial Infection Control Consortium (INICC): http://www.inicc.org

World Health Organization: Infection Prevention and Control Resources: https://www.who.int/teams/integrated-health-services/infection-prevention-control

US CDC: Infection Control Guidance for Healthcare Professionals about Coronavirus (COVID-19). https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control.html

Disclosure Policy

In accordance with the EACCME Standards for Commercial Support, the International Society for Infectious Diseases (ISID) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. ISID  resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all our educational programs. Furthermore, ISID seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. ISID is committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.

Activity Staff Disclosures:

The planners, reviewers, editors, staff, or other members at the International Society for Infectious Diseases who control content have no relevant financial relationships to disclose. 

ISID Knowledge Exchange and E-Learning Platform Organizing Committee members are listed here along with Committee members’ disclosure forms. 

Faculty Disclosures:

Prof. Gonzalo Bearman, Prof. Sade Ogunsola, Prof. Ziad Memish, Prof. Shaheen Mehta, Prof. Victor Rosenthal, and Dr. Michael Stevens have no potential conflicts of interest in relation to this program/presentation.

Dr. Michelle Doll:
Receipt of grants/research support: Molnlycke Healthcare

Disclosure of Unlabeled Use

The International Society for Infectious Diseases  requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. ISID does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

Disclaimer

The International Society for Infectious Diseases presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The International Society for Infectious Diseases, and the former commercial supporter assume no liability for the information herein.

Copyright Information

Copyright © 2021 by the International Society for Infectious Diseases. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:

•  The materials are to be used solely for personal, noncommercial, informational and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.

•  Materials may not be published, uploaded, posted, transmitted (other than as set forth herein), without the International Society for Infectious Diseases' prior written permission.

Privacy Policy

The International Society for Infectious Diseases protects the privacy of personal and other information regarding participants and educational collaborators. The International Society for Infectious Diseases will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.

The International Society for Infectious Diseases maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of information that we have collected from you.

Additional information regarding the International Society for Infectious Diseases Privacy Policy and ISID’s Knowledge Exchange and E-Learning Platform Privacy Policy can be viewed at https://isid.org/privacy-policy/ and https://exchange.isid.org/isid/legal/terms-and-conditions.

 

Infection Prevention & Control in the Wake of COVID-19

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies